Methionine Cycle and the SAM/SAH Ratio
The Cycle
| Step | Enzyme | Reaction | Note |
|---|---|---|---|
| Methionine → SAM | MAT1A (liver), MAT2A (most cells) | ATP-dependent adenosylation | The committing step |
| SAM → SAH | Methyltransferases (many) | Methyl group transferred to acceptor | The reaction of interest |
| SAH → homocysteine | AHCY | Hydrolysis, reversible | Reversibility makes SAH a signal of methyl status |
| Homocysteine → methionine | MTR (B12-dependent) | Uses 5-methyl-THF | Links to one-carbon pool |
| Homocysteine → methionine | BHMT | Uses betaine | Liver and kidney; folate-independent |
| Homocysteine → cysteine | CBS, CTH | Transsulfuration | Removes homocysteine; produces cysteine for GSH |
Important distinction. The cycle has one input (methionine, or homocysteine remethylation) and three outputs (methylation, transsulfuration, export). A change in the ratio can arise from any of them, and the ratio alone cannot say which. This is why the same observation — a low SAM/SAH ratio — is reported as "reduced methylation capacity" in some papers and "increased homocysteine export" in others.
Part 1 — What Moves the Ratio
| Manipulation | SAM | SAH | Ratio | Mechanism |
|---|---|---|---|---|
| Methionine restriction | Down | Down slightly | Down | Substrate limitation |
| Methionine excess | Up | Up | Up or unchanged | Substrate saturation; SAH rises with flux |
| Methyltransferase inhibition | Up | Down | Up | Product accumulation blocked |
| Methyl acceptor excess | Down | Up | Down | Increased transmethylation |
| Folate or B12 deficiency | Down | Up | Down | Impaired remethylation |
| Betaine supplementation | Up | Up | Slightly up | Alternative remethylation |
| MAT2A inhibition | Down | Down | Variable | Blocked synthesis |
The second row is the one that surprises: excess methionine can raise SAM and SAH together, leaving the ratio nearly unchanged while the absolute concentrations double. Reporting only the ratio in that experiment would hide the most important change.
Part 2 — Why the Ratio Is Not a Flux
Three reasons, and they compound.
- • It is a ratio of concentrations. Flux through a methyltransferase depends on SAM concentration, on the enzyme's Km, and on acceptor availability. None of these appears in the ratio.
- • SAM and SAH are compartmentalised. Nuclear SAM is produced in part by MAT2A in the nucleus in some cells, and the nuclear ratio can differ from the whole-cell ratio. Whole-cell measurements average.
- • SAH is cleared rapidly. AHCY is bidirectional and abundant, so SAH concentration reflects the balance between production and hydrolysis at the moment of sampling, not cumulative methylation.
Readout note. A methylation flux claim requires a labelled methyl group. The standard design is D₃-methionine (methyl-labelled) or D₃-SAM supplied to cells, followed by mass spectrometry of the specific methylated product — a histone peptide, a CpG, or a lipid. The increase in label incorporation over a defined window is the flux; the ratio is context.
Part 3 — Methionine Dependency
Some cell lines require exogenous methionine and cannot grow on homocysteine alone, a phenotype described as methionine dependence.
| Phenotype | Basis | Test |
|---|---|---|
| Methionine auxotrophy | Loss of methionine synthase, or of methyl-THF supply | Growth on homocysteine plus B12 and folate |
| Methionine dependency in cancer cells | Imbalance in methyl transfer; excess consumption | Growth in methionine-free, homocysteine-supplemented medium |
| Transsulfuration dependence | Cysteine demand exceeds supply | Growth with cysteine restriction |
Caveat on interpretation. Methionine dependency experiments are sensitive to folate and B12 in the medium, which are often not reported. A line that appears methionine-dependent in one formulation may grow on homocysteine in another, because the remethylation capacity differs. The medium's folate species and concentration belong in the methods.
Part 4 — Competing Consumers
SAM is consumed by many reactions, and the dominant one varies by tissue.
| Consumer | Tissue | Note |
|---|---|---|
| GNMT | Liver | Methylates glycine to sarcosine; a major SAM consumer |
| PEMT | Liver | Phosphatidylethanolamine methylation |
| DNA methyltransferases | All dividing cells | CpG methylation |
| Histone methyltransferases | All cells | Many sites, different Km |
| COMT | Brain, liver | Catecholamine catabolism |
| Creatine synthesis | Liver, kidney | Large consumer in vivo |
Important distinction. In cultured cells, the dominant SAM consumer is often not methylation of DNA or histones but a biosynthetic reaction — GNMT in hepatocytes, or PEMT where active. A treatment that reduces SAM by 30% may reduce histone methylation negligibly while affecting a high-Km reaction substantially, because affinity differs.
Part 5 — Model Requirements and Recurring Failures
| Requirement | Why |
|---|---|
| Methionine, folate and B12 concentrations stated | All three set the cycle |
| Dialysed serum documented | Serum contains methionine and folate |
| SAM and SAH reported as concentrations and ratio | The ratio alone hides magnitude |
| Sampling quenched immediately | SAM hydrolyses; SAH is cleared |
| Compartment noted if nuclear methylation is claimed | Whole-cell ratios average |
| Proliferation measured | DNA methylation demand follows replication |
Recurring failures:
- • Ratio reported without absolute values.
- • "Methylation capacity" inferred from the ratio without a labelled flux.
- • Folate and B12 unrecorded, although both determine remethylation.
- • SAM measured after a slow extraction, so hydrolysis has already occurred.
- • Nuclear methylation claims from whole-cell measurements.
- • Methionine dependency reported without the folate condition.
- • GNMT or PEMT ignored in hepatocyte models, where they dominate.
Part 6 — Where This Article Connects
This is the methyl-donor article of the amino acid cluster, and it consumes the one-carbon units produced by the serine–glycine pathway. The SAM/SAH measurement article in this cluster covers the analytical detail; the one-carbon tracing article covers the labelled designs; and the nucleotide article covers the competing use of the same folate pool.
If you need methyl flux measured with labelled methionine and compartment information, we can scope the design with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Cycle flux, dominant SAM consumers and compartmentation vary with cell type, medium composition and folate/B12 status. The patterns here are conditional.
The SAM/SAH ratio is a concentration ratio; it does not measure methylation flux or the activity of any specific methyltransferase.
Scientific interpretation and experimental design
- • One input, three outputs. The ratio conflates them.
- • Report concentrations with the ratio.
- • Flux needs a labelled methyl.
- • Compartment matters for nuclear claims.
- • Folate and B12 belong in the methods.
- • The dominant consumer is often biosynthetic, not epigenetic.
Selected references for further reading
- • Mato JM, et al. S-adenosylmethionine metabolism and liver disease. Annals of Hepatology. 2013;12:183–189.
- • Sanderson SM, et al. Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nature Reviews Cancer. 2019;19:625–637.
- • Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Annals of the New York Academy of Sciences. 2016;1363:91–98.
- • Gao X, et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature. 2019;572:397–401.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »